Evidence map›Paper›PMID 26078560›Full record

ReviewWorld journal of gastroenterology2015

Endoscopic treatment of gastroparesis.

Thomas R McCarty, Tarun Rustagi

Abstract readReview
In one paragraph

Review in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Gastroparesis: New insights into an old disease.World journal of gastroenterology · 2020
    Review
  6. Article
  7. Article
  8. Review
  9. Effect ofElectronic physician · 2018
    Article
  10. How I Do It: Per-Oral Pyloromyotomy (POP).Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2017
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Thomas R McCartyThomas R McCarty, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520-8019, United States.
Tarun RustagiThomas R McCarty, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520-8019, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastroparesis has traditionally been a largely medically managed disease with refractory symptoms typically falling under the umbrella of the surgical domain. Surgical options include, but are not limited to, gastrostomy, jejunostomy, pyloromyotomy, or pyloroplasty, and the Food and Drug Administration approved gastric electrical stimulation implantation. Endoscopic management of gastroparesis most commonly involves intrapyloric botulinum toxin injection; however, there exists a variety of endoscopic approaches on the horizon that have the potential to radically shift standard of care. Endoscopic management of gastroparesis seeks to treat delayed gastric emptying with a less invasive approach compared to the surgical approach. This review will serve to highlight such innovative and potentially transformative, endoscopic interventions available to gastroenterologists in the management of gastroparesis.

Indexed as

Gastric EmptyingAnimalsBotulinum ToxinsDecompression, SurgicalElectric Stimulation TherapyGastric BypassGastroparesisGastroscopyHumansInjectionsNeuromuscular AgentsRecovery of FunctionStentsTreatment OutcomeBotulinum ToxinsNeuromuscular AgentsBotulinumGastric pacemakerGastric stimulatorGastrojejunostomyPyloromyotomyStentingTranspyloric

Identifiers

PMID26078560
PMCPMC4462724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.